Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: The Korean Sarcopenic Obesity Study

Clinical Endocrinology

Volumn 78, Issue 4, 2013, Pages 525-532

  Kim, Tae Nyun ^a,b   Park, Man Sik ^c   Lim, Kang Il ^a   Choi, Hae Yoon ^a   Yang, Sae Jeong ^a   Yoo, Hye Jin ^a   Kang, Hyun Joo ^d   Song, Wook ^e   Choi, Hyuk ^a   Baik, Sei Hyun ^a   Choi, Dong Seop ^a   Choi, Kyung Mook ^a,f  

^a Korea University College of Medicine   (South Korea)

^b Inje University   (South Korea)

^c Sungshin Women's University   (South Korea)

^d Soonchunhyang University   (South Korea)

^e Seoul National University   (South Korea)

^f Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN;

ADULT; ARTICLE; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MALE; MUSCLE ATROPHY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOPENIC OBESITY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PREVALENCE; REPUBLIC OF KOREA; SARCOPENIA; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84875145642     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04433.x     Document Type: Article

References (33)

1. Newman, A.B., Lee, J.S., Visser, M., et al,. (2005) Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. American Journal of Clinical Nutrition, 82, 872-878; quiz 915-876.
2. Zamboni, M., Mazzali, G., Fantin, F., et al,. (2008) Sarcopenic obesity: a new category of obesity in the elderly. Nutrition, Metabolism, and Cardiovascular Diseases, 18, 388-395.
3. Jensen, G.L., (2008) Inflammation: roles in aging and sarcopenia. Journal of Parenteral and Enteral Nutrition, 32, 656-659.
4. Rasmussen, B.B., Fujita, S., Wolfe, R.R., et al,. (2006) Insulin resistance of muscle protein metabolism in aging. FASEB Journal, 20, 768-769.
5. Sayer, A.A., Syddall, H.E., Dennison, E.M., et al,. (2007) Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study. QJM, 100, 707-713.
6. Cesari, M., Kritchevsky, S.B., Baumgartner, R.N., et al,. (2005) Sarcopenia, obesity, and inflammation-results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. American Journal of Clinical Nutrition, 82, 428-434.
7. Schaap, L.A., Pluijm, S.M., Deeg, D.J., et al,. (2006) Inflammatory markers and loss of muscle mass (sarcopenia) and strength. American Journal of Medicine, 119, 526.e9-e17.
8. Schaap, L.A., Pluijm, S.M., Deeg, D.J., et al,. (2009) Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 64, 1183-1189.
9. Baz-Hecht, M., &, Goldfine, A.B., (2010) The impact of vitamin D deficiency on diabetes and cardiovascular risk. Current Opinion in Endocrinology, Diabetes, and Obesity, 17, 113-119.
10. Visser, M., Deeg, D.J., &, Lips, P., (2003) Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. Journal of Clinical Endocrinology and Metabolism, 88, 5766-5772.
11. Kim, T.N., Yang, S.J., Yoo, H.J., et al,. (2009) Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. International Journal of Obesity, 33, 885-892.
12. Kim, T.N., Park, M.S., Yang, S.J., et al,. (2010) Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care, 33, 1497-1499.
13. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al,. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
14. Grundy, S.M., Cleeman, J.I., Daniels, S.R., et al,. (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiology in Review, 13, 322-327.
15. Janssen, I., Heymsfield, S.B., &, Ross, R., (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. Journal of the American Geriatrics Society, 50, 889-896.
16. Japan Society for the Study of Obesity. (2002) The Examination Committee of Criteria for 'Obesity Disease' in Japan. New criteria for 'obesity disease' in Japan. Circulation Journal, 66, 987-992.
17. Baumgartner, R.N., Wayne, S.J., Waters, D.L., et al,. (2004) Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obesity Research, 12, 1995-2004.
18. Messier, V., Karelis, A.D., Lavoie, M.E., et al,. (2009) Metabolic profile and quality of life in class I sarcopenic overweight and obese postmenopausal women: a MONET study. Applied Physiology, Nutrition and Metabolism, 34, 18-24.
19. Stephen, W.C., &, Janssen, I., (2009) Sarcopenic-obesity and cardiovascular disease risk in the elderly. The Journal of Nutrition, Health and Aging, 13, 460-466.
20. Bastard, J.P., Maachi, M., Lagathu, C., et al,. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network, 17, 4-12.
21. Stenholm, S., Harris, T.B., Rantanen, T., et al,. (2008a) Sarcopenic obesity: definition, cause and consequences. Current Opinion in Clinical Nutrition and Metabolic Care, 11, 693-700.
22. Abbatecola, A.M., Ferrucci, L., Ceda, G., et al,. (2005) Insulin resistance and muscle strength in older persons. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 60, 1278-1282.
23. Park, S.W., Goodpaster, B.H., Strotmeyer, E.S., et al,. (2007) Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care, 30, 1507-1512.
24. Honda, H., Qureshi, A.R., Axelsson, J., et al,. (2007) Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. American Journal of Clinical Nutrition, 86, 633-638.
25. Schrager, M.A., Metter, E.J., Simonsick, E., et al,. (2007) Sarcopenic obesity and inflammation in the InCHIANTI study. Journal of Applied Physiology, 102, 919-925.
26. Stenholm, S., Rantanen, T., Heliovaara, M., et al,. (2008b) The mediating role of C-reactive protein and handgrip strength between obesity and walking limitation. Journal of the American Geriatrics Society, 56, 462-469.
27. Despres, J.P., (2006) Is visceral obesity the cause of the metabolic syndrome? Annals of Medicine, 38, 52-63.
28. Lim, S., Kim, J.H., Yoon, J.W., et al,. (2010) Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care, 33, 1652-1654.
29. Orwoll, E., Nielson, C.M., Marshall, L.M., et al,. (2009) Vitamin D deficiency in older men. Journal of Clinical Endocrinology and Metabolism, 94, 1214-1222.
30. Holick, M.F., (2007) Vitamin D deficiency. New England Journal of Medicine, 357, 266-281.
31. Siddiqui, S.M., Chang, E., Li, J., et al,. (2008) Dietary intervention with vitamin D, calcium, and whey protein reduced fat mass and increased lean mass in rats. Nutrition Research, 28, 783-790.
32. Scott, D., Blizzard, L., Fell, J., et al,. (2010) A prospective study of the associations between 25-hydroxy-vitamin D, sarcopenia progression and physical activity in older adults. Clinical Endocrinology (Oxford), 73, 581-587.
33. Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., et al,. (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age and Ageing, 39, 412-423.